Recurrent carotid paragangliomas in a syndromic patient with a heterozygous missense variant in DNA Methyltransferase 3 Alpha

Am J Med Genet A. 2025 Jan;197(1):e63849. doi: 10.1002/ajmg.a.63849. Epub 2024 Aug 21.

Abstract

We report a 40-year-old African American female with a novel variant in exon 8 of DNA methyltransferase 3 alpha (DNMT3A), (NM_022552.4: c.905G>C, p.G302A) who presented with a history of recurrent carotid paragangliomas, mediastinal mass, intellectual disability, dysarthria, cholelithiasis, diabetes mellitus, hypertension, and dysmorphic features. We interpret this novel variant as likely pathogenic and causative for the patient's syndromic features of Heyn-Sproul-Jackson syndrome. Heyn-Sproul-Jackson syndrome is a condition caused by gain-of-function genetic changes in DNMT3A. Paragangliomas have also been observed in non-syndromic patients with genetic alterations in DNMT3A. We describe a patient with clinical features of Heyn-Sproul-Jackson syndrome such as intellectual disability, dysarthria, brachydactyly, and lack of brain MRI findings to add evidence to associate paragangliomas with DNMT3A and draw particular attention to the potential involvement of the proline-tryptophan-tryptophan-proline domain of DNMT3A.

Keywords: DNMT3A; exome sequencing; hypermethylation; paraganglioma.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • DNA (Cytosine-5-)-Methyltransferases* / genetics
  • DNA Methyltransferase 3A*
  • Female
  • Heterozygote
  • Humans
  • Intellectual Disability / genetics
  • Intellectual Disability / pathology
  • Mutation, Missense* / genetics
  • Paraganglioma* / diagnostic imaging
  • Paraganglioma* / genetics
  • Paraganglioma* / pathology
  • Phenotype
  • Syndrome

Substances

  • DNA Methyltransferase 3A
  • DNMT3A protein, human
  • DNA (Cytosine-5-)-Methyltransferases